Personalized Hemodynamic Resuscitation Targeting Capillary Refill Time in Early Septic Shock

医学 感染性休克 毛细管再灌注 复苏 血流动力学 休克(循环) 早期目标导向治疗 麻醉 急诊医学 重症监护医学 心脏病学 内科学 败血症 失血性休克 梅德林 血流 心肺复苏术
作者
Fernando Pálizas,Bernardo Lattanzio,Natalia Durandal,María Eugenia Alonso,J. Duque,Nicolas Falcon,Ruben A. Mesa,Martín Hunter,Mario Omar Pozo,Facundo Gutiérrez,Santiago Sac,Nicole Goette,Sebastián Consalvo,Pilar Zamudio,Gastón Murias,Juan Carlos Pendino,Lisandro Roberto Bettini,Juan Ignacio Ibarzábal,Valentin Torres,Federico Fiorilli
出处
期刊:JAMA [American Medical Association]
卷期号:334 (22): 1988-1988 被引量:64
标识
DOI:10.1001/jama.2025.20402
摘要

Importance: The optimal strategy for hemodynamic resuscitation in early septic shock remains uncertain. Objective: To determine the effect of a personalized hemodynamic resuscitation protocol targeting capillary refill time (CRT-PHR) on a hierarchical composite outcome of mortality, duration of vital support, and length of hospital stay. Design, Setting, and Participants: This randomized clinical trial was conducted in 86 centers in 19 countries. Patients within the first 4 hours of septic shock were included between March 2022 and April 2025, with last follow-up in July 2025. Interventions: Patients were randomized to undergo CRT-PHR (n = 720), including assessment of pulse pressure, diastolic arterial pressure, fluid responsiveness, and bedside echocardiography, to tailor fluids, vasopressors, and inotropes, vs usual care (n = 747). Main Outcomes and Measures: The primary outcome was a hierarchical composite of mortality, duration of vital support (vasoactives, mechanical ventilation, and kidney replacement therapy), and length of hospital stay assessed at 28 days. A win ratio was calculated for the primary outcome by comparing all possible patient pairs, starting with the first event in the hierarchy and stratified by median APACHE (Acute Physiology and Chronic Health Evaluation) II score at admission. Secondary outcomes were mortality, vital support-free days, and length of hospital stay at 28 days. Results: From 1501 randomized patients, 1467 were included in the primary analysis (mean age, 66 [17] years; 43.3% female). There were 131 131 wins (48.9%) in the CRT-PHR group vs 112 787 (42.1%) in the usual care group for the hierarchical composite primary outcome, with a win ratio of 1.16 (95% CI, 1.02-1.33; P = .04). Individual wins for death were 19.1% vs 17.8%; duration of vital support, 26.4% vs 21.1%; and length of hospital stay, 3.4% vs 3.2% in the intervention vs usual care groups, respectively. Conclusions and Relevance: Among patients with early septic shock, a personalized hemodynamic resuscitation protocol targeting capillary refill time was superior to usual care for the primary composite outcome, primarily due to a lower duration of vital support. Trial Registration: ClinicalTrials.gov Identifier: NCT05057611.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
Ceci发布了新的文献求助10
1秒前
1秒前
酷波er的应助被bobo采纳,获得10
2秒前
2秒前
歌者完成签到,获得积分10
2秒前
FANG完成签到,获得积分10
2秒前
HouKk发布了新的文献求助10
2秒前
3秒前
doctorpan完成签到 ,获得积分10
4秒前
石濑汤汤发布了新的文献求助10
5秒前
orixero的应助被ZHANGJK采纳,获得10
5秒前
老实芭蕉发布了新的文献求助10
5秒前
5秒前
Zhang发布了新的文献求助10
5秒前
6秒前
睢先生发布了新的文献求助10
6秒前
李志强发布了新的文献求助10
6秒前
彭心瑶完成签到,获得积分10
6秒前
科研通AI6.2的应助被风趣幻枫采纳,获得10
8秒前
爆米花的应助被王冬瓜采纳,获得30
9秒前
SciGPT的应助被Wxj246801采纳,获得10
9秒前
wanci的应助被希望早睡采纳,获得10
9秒前
9秒前
黑桃3发布了新的文献求助10
10秒前
10秒前
10秒前
Hello的应助被小石头采纳,获得10
10秒前
11秒前
11秒前
明德zhuang发布了新的文献求助10
11秒前
科研通AI6.2的应助被F衣衫褴褛采纳,获得10
13秒前
潇洒诗槐发布了新的文献求助10
14秒前
babyshelling发布了新的文献求助20
14秒前
王伊人关注了科研通微信公众号
14秒前
subulaxi发布了新的文献求助10
14秒前
优美初曼发布了新的文献求助10
14秒前
14秒前
南巷初晴完成签到,获得积分10
15秒前
nephron发布了新的文献求助10
15秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Rosenblum, Global Change Biology 800
自動車の空力技術 800
Organizational Behavior 510
Management and the Arts 510
Geschichtliche Grundbegriffe (GGB), Band 5: Pro–Soz 300
Die Religion in Geschichte und Gegenwart (RGG), 4. Auflage, Band 7: R–S 300
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 化学工程 工程类 有机化学 物理 复合材料 生物化学 内科学 细胞生物学 基因 遗传学 免疫学 冶金 光电子学 癌症研究
热门帖子
关注 科研通微信公众号,转发送积分 7790022
求助须知:如何正确求助?哪些是违规求助? 9327554
关于积分的说明 20418946
捐赠科研通 7379554
什么是DOI,文献DOI怎么找? 3322967
关于科研通互助平台的介绍 2470897
邀请新用户注册赠送积分活动 2339810